Verrica Pharmaceuticals Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • Verrica Pharmaceuticals Inc. Operating Margin for the quarter ending September 30, 2024 was -843 %, a 44.7% increase year-over-year.
  • Verrica Pharmaceuticals Inc. annual Operating Margin for 2023 was -1.28K %, a 444% decline from 2022.
  • Verrica Pharmaceuticals Inc. annual Operating Margin for 2022 was -236 %, a 8.46% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -843 +681 +44.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -581 -309 -113% Apr 1, 2024 Jun 30, 2024
Q1 2024 -867 -624 -257% Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.28K -1.05K -444% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.52K -1.26K -480% Jul 1, 2023 Sep 30, 2023
Q2 2023 -273 +5.43K +95.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -243 +8.66K +97.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -236 +21.8 +8.46% Oct 1, 2022 Dec 31, 2022
Q3 2022 -263 Jul 1, 2022 Sep 30, 2022
Q2 2022 -5.7K Apr 1, 2022 Jun 30, 2022
Q1 2022 -8.9K Jan 1, 2022 Mar 31, 2022
Q4 2021 -258 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.